logo
Search
  • Emselex

    Emselex

    Emselex sustained release tablets is an original drug that that contains 7,5 or 15 mg Darifenacin. Emselex is classified as an urological spasmolytic agent and is indicated for symptomatic treatment of urge incontinence and/or increased micturition frequency and urgency which can happen among adult patients with overactive bladder. The active substance Darifenacine is a muscarinic receptor antagonist that specifically blocks the M3 receptor.

    Indications
    Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome.

    Dosage
    Adults: The recommended starting dose is 7.5 mg daily. After 2 weeks of starting therapy, patients should be reassessed. For those patients requiring greater symptom relief, the dose may be increased to 15 mg daily, based on individual response. Elderly patients (≥ 65 years): The recommended starting dose for the elderly is 7.5 mg daily. After 2 weeks of starting therapy, patients should be reassessed for efficacy and safety. For those patients who have an acceptable tolerability profile but require greater symptom relief, the dose may be increased to 15 mg daily, based on individual response.

    Active substance
    Darifenacine is the active substance in Emselex, each prolonged release tablet contains 7,5 or 15 mg of Darifenacine.

    Package size
    Blister pack with 98 prolonged release tablets of each strength (7,5 and 15 mg)

    More information
    http://pro.medicin.dk/Medicin/Praeparater/3576

    Leave a reply →